SEC Tracker
Get the app

Integra Lifesciences Holdings IART

Integra LifeSciences Reports Second Quarter 2021 Financial Results

Form
8-K
Filed
Period
Importance
Major
Document
8-K
Exhibit 99.1
Press release
  • Reports quarterly results (2.02)

Not explained yet; the original is on EDGAR.

View on EDGAR

Open in the app

Get an email when Integra Lifesciences Holdings files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 3841 and related industry codes: the same peer list as the financial tables.

  1. Establishment Labs Holdings ESTA public float $975M, Jun 30, 2025
  2. NovoCure NVCR public float $995M, Jun 30, 2025
  3. Biolife Solutions BLFS public float $845M, Jun 30, 2025
  4. SI-BONE SIBN public float $800M, Jun 30, 2025
  5. Embecta EMBC public float $732M, Mar 31, 2025, over 18 months old

Data on this page was fetched . The filing on SEC.gov is the record.